Designer baby

Designer baby is a term used to describe a baby whose genetic makeup has been artificially selected or altered, often to ensure the presence or absence of particular genes or characteristics. This is done through a process known as preimplantation genetic diagnosis (PGD), which involves screening embryos created through in vitro fertilisation (IVF) for specific genetic traits.

History

The concept of designer babies has been present in scientific discussions since the advent of genetic engineering and artificial insemination. However, it was not until the development of PGD in the 1990s that the possibility of creating designer babies became a reality.

Ethical considerations

The idea of designer babies raises numerous ethical issues. Some people argue that it is unethical to manipulate the genes of an unborn child, while others believe that it could lead to a new form of eugenics, where people could choose the traits of their children based on personal preferences rather than health needs.

Legal status

The legal status of designer babies varies from country to country. In some countries, such as the UK, the use of PGD for non-medical reasons is prohibited. However, in other countries, such as the US, there are no specific laws regulating the use of this technology.

Future implications

The future implications of designer babies are still uncertain. Some experts believe that this technology could lead to significant advancements in the field of genetics, while others fear that it could lead to a society where genetic inequality is the norm.

See also

• Genetic engineering
• Preimplantation genetic diagnosis
• In vitro fertilisation
• Eugenics

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

   This article is a medical stub. You can help WikiMD by expanding it!

Designer_baby

• 
  Preimplantation Genetic Diagnosis Process
• 
  Guide RNA and Cas9 Interaction
• 
  DNA Repair Mechanism
• 
  He Jiankui at Second International Summit on Human Genome Editing